Guardant Health, Inc.
GH
$44.59
-$1.58-3.42%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -4.98% | 14.28% | -3.02% | -4.99% | 10.75% |
Total Depreciation and Amortization | -1.90% | -2.09% | -1.36% | -0.24% | -0.83% |
Total Amortization of Deferred Charges | -- | -- | 0.16% | -- | -- |
Total Other Non-Cash Items | 9.31% | 19.22% | -33.70% | 11.51% | -21.81% |
Change in Net Operating Assets | 13.27% | -724.08% | 76.78% | 77.28% | -782.57% |
Cash from Operations | 3.83% | 2.83% | -26.35% | 45.68% | -210.40% |
Capital Expenditure | -26.69% | 76.38% | -349.51% | 17.29% | 26.78% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -101.63% | 945.14% | 110.12% | -- | -100.00% |
Cash from Investing | -103.52% | 2,776.20% | 103.57% | -5,707.11% | -118.09% |
Total Debt Issued | -200.00% | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 1,102.73% | -84.73% | 25,045.00% | -99.79% | 4,395.77% |
Repurchase of Common Stock | 87.74% | -654.17% | -179.16% | 11.30% | -109.84% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 139.85% | -20,677.97% | 290.32% | 92.92% | -270.43% |
Cash from Financing | 102.43% | -2,177.68% | -1.73% | -148.91% | 649.16% |
Foreign Exchange rate Adjustments | 21.22% | 145.60% | -189.21% | 327.00% | 26.45% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -139.27% | 397.03% | 83.10% | -268.94% | -2,022.30% |